0T6G.L
Q32 Bio Inc. is a clinical-stage biotechnology company, headquartered in Waltham, Massachusetts, focused on creating innovative biologic treatments. Operating within the United States, its primary objective is to re-establish a healthy immune balance in individuals suffering from autoimmune and inflammatory conditions stemming from pathological immune dysfunction. The company's primary therapeutic candidate, ADX-097, is a humanized monoclonal antibody fusion protein engineered to restore proper complement regulation. This compound has successfully concluded its Phase I clinical trial and is being advanced for the treatment of severe renal and other complement-mediated diseases that present s...[Read more]
Industry
Biotechnology
IPO Date
2018-10-04
Stock Exchange
LSE
Ticker
0T6G.L
According to Q32 Bio Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 4.47. This represents a change of -536.70% compared to the average of -1.02 of the last 4 quarters.
The mean historical PE Ratio of Q32 Bio Inc. over the last ten years is -13.77. The current 4.47 PE Ratio has changed -3345.40% with respect to the historical average. Over the past ten years (40 quarters), 0T6G.L's PE Ratio was at its highest in in the March 2024 quarter at 52.14. The PE Ratio was at its lowest in in the March 2021 quarter at -111.43.
Average
-13.77
Median
-3.06
Minimum
-86.79
Maximum
1.37
Discovering the peaks and valleys of Q32 Bio Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.56%
Maximum Annual PE Ratio = 1.37
Minimum Annual Increase = -304.19%
Minimum Annual PE Ratio = -86.79
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 1.37 | -304.19% |
| 2024 | -0.67 | 2.56% |
| 2023 | -0.66 | -61.24% |
| 2022 | -1.69 | -19.57% |
| 2021 | -2.10 | -47.82% |
| 2020 | -4.03 | -52.00% |
| 2019 | -8.39 | -26.96% |
| 2018 | -11.49 | -50.69% |
| 2017 | -23.29 | -73.16% |
The current PE Ratio of Q32 Bio Inc. (0T6G.L) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
0.01
5-year avg
-0.75
10-year avg
-13.77
Q32 Bio Inc.’s PE Ratio is greater than Kyntra Bio, Inc. (0.18), greater than Lite Strategy, Inc. (-0.11), greater than Adicet Bio, Inc. (-0.59), greater than Sorrento Therapeutics, Inc. (-0.00), greater than Affimed N.V. (-0.00), greater than KALA BIO, Inc. (-0.41), greater than Atara Biotherapeutics Inc (-14.79), greater than Insight Molecular Diagnostics Inc. (-3.35), greater than Corbus Pharmaceuticals Holdings, Inc. (-1.47), greater than Aclaris Therapeutics, Inc. (-9.96),
| Company | PE Ratio | Market cap |
|---|---|---|
| 0.18 | N/A | |
| -0.11 | N/A | |
| -0.59 | N/A | |
| -0.00 | N/A | |
| -0.00 | N/A | |
| -0.41 | N/A | |
| -14.79 | N/A | |
| -3.35 | N/A | |
| -1.47 | N/A | |
| -9.96 | N/A |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Q32 Bio Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Q32 Bio Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Q32 Bio Inc.'s PE Ratio?
How is the PE Ratio calculated for Q32 Bio Inc. (0T6G.L)?
What is the highest PE Ratio for Q32 Bio Inc. (0T6G.L)?
What is the 3-year average PE Ratio for Q32 Bio Inc. (0T6G.L)?
What is the 5-year average PE Ratio for Q32 Bio Inc. (0T6G.L)?
How does the current PE Ratio for Q32 Bio Inc. (0T6G.L) compare to its historical average?